Romiplostim for the treatment of chronic immune or idiopathic thrombocytopenic purpura
| dc.contributor.author | Mowatt, Graham | |
| dc.contributor.author | Boachie, Charles | |
| dc.contributor.author | Crowther, Mark | |
| dc.contributor.author | Fraser, Cynthia Mary | |
| dc.contributor.author | Hernandez, Rodolfo Andres | |
| dc.contributor.author | Jia, Xueli | |
| dc.contributor.author | Ternent, Laura | |
| dc.contributor.institution | University of Aberdeen.Other Applied Health Sciences | en |
| dc.contributor.institution | University of Aberdeen.Health Economics Research Unit | en |
| dc.date.accessioned | 2012-04-03T09:27:00Z | |
| dc.date.available | 2012-04-03T09:27:00Z | |
| dc.date.issued | 2009-09 | |
| dc.description.status | Peer reviewed | en |
| dc.format.extent | 6 | |
| dc.format.extent | 759465 | |
| dc.identifier | 1132610 | |
| dc.identifier | 00048cbf-d453-48e2-9a57-7fbf91a436e9 | |
| dc.identifier | 000273002600010 | |
| dc.identifier | 84886943103 | |
| dc.identifier.citation | Mowatt, G, Boachie, C, Crowther, M, Fraser, C M, Hernandez, R A, Jia, X & Ternent, L 2009, 'Romiplostim for the treatment of chronic immune or idiopathic thrombocytopenic purpura', Health Technology Assessment, vol. 13, no. Suppl 2, pp. 63-68. https://doi.org/10.3310/hta13suppl2/09 | en |
| dc.identifier.doi | 10.3310/hta13suppl2/09 | |
| dc.identifier.issn | 2046-4924 | |
| dc.identifier.other | ORCID: /0000-0003-2619-8230/work/162727157 | |
| dc.identifier.uri | http://hdl.handle.net/2164/2374 | |
| dc.identifier.vol | 13 | en |
| dc.language.iso | eng | |
| dc.relation.ispartof | Health Technology Assessment | en |
| dc.subject | SDG 3 - Good Health and Well-being | en |
| dc.subject | R Medicine | en |
| dc.subject.lcc | R | en |
| dc.title | Romiplostim for the treatment of chronic immune or idiopathic thrombocytopenic purpura | en |
| dc.type | Journal article | en |